Buy or sell Emulate stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Emulate Stock

Emulate, Inc. is a private company focused on commercializing Organs-on-Chips.

Founded

2013

Notable Investors

NanoDimension

Headquarters

Boston MA, US

Total Funding

$95.0M

About Emulate Stock

Emulate, Inc. is a private company focused on commercializing Organs-on-Chips as an automated human bioemulation platform that achieves a new standard for mimicking true human physiology so that responses to medicines, chemicals and diseases can be accurately predicted. Through co-innovation with collaborators and internal programs, Emulate is advancing product innovation, design and safety across a range of applications in drug development, personalized medicine, agriculture and chemical-based consumer products.

Investors

Funding History

July 2014$12.0M
March 2016$28.0M
October 2016$17.0M
June 2017$2.0M
June 2018$36.0M

Management

Co-Founder and CSO

Geraldine A. Hamilton

Co-Founder and CEO

James Coon

Co-Founder and Chief Technology Officer

Daniel Levner

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Emulate or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo